People · Operator
Named in public records as an officer, director or promoter · active 2015–2015 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Genebiology, Inc. | — | Pharmaceuticals | Pre-Seed | $400K | $18.9M | 2015 |
DAVID W. MOTTOLA, PHD at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside DAVID W. MOTTOLA, PHD on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| JIM W. COOPER | 1 | 1 |
| JAMES W. CROW, PHD | 1 | 1 |
| WALKER A. LONG, MD | 1 | 1 |
| JOHAN W. PRETORIUS, MD, MBA | 1 | 1 |
| GREG W. GILBERT | 1 | 1 |
| CATHARINA W. SEVILLANO | 1 | 1 |
| CHRIS W. WEBSTER | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.